Female Genital Organ Cancer Samples
The category Female Genital Organ Cancer Samples comprises human biospecimens which were measured for the following laboratory parameters: Cancer-Antigen 125, Carcino Embryonic Antigen, Lactate dehydrogenase and Neuron-specific enolase. You can use our filter functions to refine your search. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.
85 Products
Human Serum - Cancer-Antigen 125 (CA 125) - C55
- Donor:
- Gender: Female Age: 67
- Diagnosed disease:
- C55
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 67 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- C55
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 54.60 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275711
0.5 mL (€81.25)
Human Serum - Cancer-Antigen 125 (CA 125) - C54.1
- Donor:
- Gender: Female Age: 77
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 77 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 54.80 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275705
0.5 mL (€81.25)
Human Serum - Neuron-specific enolase (NSE) - C54.1
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Neuron-specific enolase (NSE)
Donor:
- Gender:
- Female
- Age:
- 64 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Neuron-specific enolase (NSE) |
Qual: positive
Quant: 15.00 µg/L
Source: this donation
|
< 15 µg/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH275720
0.6 mL (€97.50)
Human Serum - C54.1
- Donor:
- Gender: Female Age: 79
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 79 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: negative
Quant: 14.40 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283543
1 mL (€162.50)
Human Serum - C57.4
- Donor:
- Gender: Female Age: 61
- Diagnosed disease:
- C57.4 - Malignant neoplasm of uterine adnexa, unspecified
- Parameter:
- Carcino Embryonic Antigen (CEA)
Donor:
- Gender:
- Female
- Age:
- 61 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of uterine adnexa, unspecified [C57.4]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Carcino Embryonic Antigen (CEA) |
Qual: negative
Quant: 1.70 ng/mL
Source: this donation
|
< 4.6 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283534
1 mL (€162.50)
Human Serum - Cancer-Antigen 125 (CA 125) - C54.1
- Donor:
- Gender: Female Age: 76
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 76 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 72.60 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283562
1 mL (€162.50)
Human Serum - Cancer-Antigen 125 (CA 125) - C57.4
- Donor:
- Gender: Female Age: 61
- Diagnosed disease:
- C57.4 - Malignant neoplasm of uterine adnexa, unspecified
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 61 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of uterine adnexa, unspecified [C57.4]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 186.90 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280606
1.1 mL (€178.75)
Human Serum - C54.8
- Donor:
- Gender: Female Age: 83
- Diagnosed disease:
- C54.8 - Malignant neoplasm of overlapping lesion of corpus uteri
- Parameter:
- Lactate dehydrogenase (LDH)
Donor:
- Gender:
- Female
- Age:
- 83 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of corpus uteri [C54.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Lactate dehydrogenase (LDH) |
Qual: negative
Quant: 3.14 µmol/s/L
Source: this donation
|
< 4.16 µmol/s/L
|
Method: Photometry System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280629
1.1 mL (€178.75)
Human Serum - Lactate dehydrogenase (LDH) - C51.8
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Lactate dehydrogenase (LDH)
Donor:
- Gender:
- Female
- Age:
- 78 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Lactate dehydrogenase (LDH) |
Qual: positive
Quant: 6.67 µmol/s/L
Source: this donation
|
< 4.16 µmol/s/L
|
Method: Photometry System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280643
1.1 mL (€178.75)
Human Serum - Cancer-Antigen 125 (CA 125) - C54.1
- Donor:
- Gender: Female Age: 63
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 63 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 271.90 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280724
1.1 mL (€178.75)
Human Serum - Cancer-Antigen 125 (CA 125) - C57.4
- Donor:
- Gender: Female Age: 61
- Diagnosed disease:
- C57.4 - Malignant neoplasm of uterine adnexa, unspecified
- Parameter:
- Cancer-Antigen 125 (CA 125)
Donor:
- Gender:
- Female
- Age:
- 61 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of uterine adnexa, unspecified [C57.4]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 125 (CA 125) |
Qual: positive
Quant: 316.00 U/mL
Source: this donation
|
< 35 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280600
1.4 mL (€227.50)
Human Serum - Procalcitonin (PCT) - C57.0
- Donor:
- Gender: Female Age: 72
- Diagnosed disease:
- C57.0 - Malignant neoplasm of fallopian tube
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 72 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of fallopian tube [C57.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.15 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284077
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C51.8
- Donor:
- Gender: Female Age: 68
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.87 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286948
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C54.9
- Donor:
- Gender: Female Age: 76
- Diagnosed disease:
- C54.9 - Malignant neoplasm of corpus uteri, unspecified
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 76 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of corpus uteri, unspecified [C54.9]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 2.26 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286883
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C54.2
- Donor:
- Gender: Female Age: 62
- Diagnosed disease:
- C54.2 - Malignant neoplasm of myometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 62 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of myometrium [C54.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.02 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286866
0.5 mL (€18.75)
Human Serum - C54.1
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 64 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: negative
Quant: 0.58 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH286870
0.5 mL (€18.75)
Human Serum - Procalcitonin (PCT) - C57.0
- Donor:
- Gender: Female Age: 72
- Diagnosed disease:
- C57.0 - Malignant neoplasm of fallopian tube
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 72 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of fallopian tube [C57.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 9.00 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284073
0.6 mL (€22.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C51.8
- Donor:
- Gender: Female Age: 68
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 68 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.87 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH182996
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C57.0
- Donor:
- Gender: Female Age: 74
- Diagnosed disease:
- C57.0 - Malignant neoplasm of fallopian tube
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 74 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of fallopian tube [C57.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 2.35 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107470
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C54.9
- Donor:
- Gender: Female Age: 76
- Diagnosed disease:
- C54.9 - Malignant neoplasm of corpus uteri, unspecified
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 76 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of corpus uteri, unspecified [C54.9]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 2.26 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107742
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C54.2
- Donor:
- Gender: Female Age: 62
- Diagnosed disease:
- C54.2 - Malignant neoplasm of myometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 62 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of myometrium [C54.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.02 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH109177
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C51.8
- Donor:
- Gender: Female Age: 60
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 60 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.85 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH160965
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C54.1
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 78 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.96 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH171150
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C54.1
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 78 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.96 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283210
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C56
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C56
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 78 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- C56
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.66 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234000
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C56
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C56
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 78 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- C56
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.03 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234003
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C56
- Donor:
- Gender: Female Age: 69
- Diagnosed disease:
- C56
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 69 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- C56
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.59 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234214
1 mL (€37.50)
Human K3EDTA plasma - C54.1
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- C54.1 - Malignant neoplasm of endometrium
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 64 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of endometrium [C54.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: negative
Quant: 0.58 ng/mL
Source: this donation
|
< 0.60 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107182
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C51.8
- Donor:
- Gender: Female Age: 60
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 60 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.85 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH277758
1.1 mL (€41.25)
Human Serum - Procalcitonin (PCT) - C51.8
- Donor:
- Gender: Female Age: 60
- Diagnosed disease:
- C51.8 - Malignant neoplasm of overlapping lesion of vulva
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 60 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of vulva [C51.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.55 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: EIA (Enzyme Immuno Assay) System: cobas 8000 Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH277755
1.1 mL (€41.25)
